Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Pilot Study of Intravitreal Injection of Ranibizumab (rhuFAB V2) for Advanced Ocular Disease of Von Hippel-Lindau (VHL) Disease

NCT00089765 is registered in ClinicalTrials.gov with National Eye Institute (NEI) as lead sponsor.

NCT NCT00089765
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00089765 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Pilot Study of Intravitreal Injection of Ranibizumab (rhuFAB V2) for Advanced Ocular Disease of Von Hippel-Lindau (VHL) Disease
Lead sponsor
National Eye Institute (NEI)
Phase
Phase 1
Overall status
Completed
Start date
August 10, 2004
Completion date
August 15, 2007
Enrollment
5
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

von hippel-lindau syndrome